[1] 顾玉东.皮瓣的静脉危象及其处理[J].中华手外科杂志, 1996,12(3):131-133.[2] Kroll SS, Schusterman MA, Reece GP, et al. Timing of pedicle thrombosis and flap loss after free-tissue transfer. Plastic and reconstructive surgery.1996; 98 (7): 1230-1233.[3] Brown J, Devine J, Magennis P, et al. Factors that influence the outcome of salvage in free tissue transfer. Br J Oral Maxillofac Surg.2003; 41(1): 16-20.[4] da Rocha FP, Fagundes DJ, Pires JA,et al. Effects of hyperbaric oxygen and N-acetylcysteine in survival of random pattern skin flaps in rats. Indian J Plast Surg. 2012;45(3):453-458.[5] 邓炳海,申晓红,李爱民,等.皮瓣移植术后早期介入高压氧治疗效果[J]. 中国组织工程研究与临床康复,2007,11(4): 756-757.[6] 吴琍,任纪祯,陈振雨,等.高压氧对大鼠超长随意皮瓣成活率的影响[J]. 中华航海医学与高气压医学杂志,2008, 15(5):279-282.[7] 戚征,高春锦,孙学军,等.高压氧预处理促进皮瓣成活的研究[J].中华医学美学美容杂志,2009,15(1):46-48.[8] 赵永刚,范金才.静脉淤血皮瓣的微循环研究[J].中华医学美学美容杂志, 2008,14(5):330-333.[9] Harashina T, Sawada Y, Watanabe S.The relationship between venous occlusion time in island flaps and flap survivals. Plast Reconstr Surg. 1977; 60 (1): 92-95.[10] Hidalgo DA, Jones CS. The role of emergent exploration in free-tissue transfer: a review of 150 consecutive cases. Plast Reconstr Surg. 1990;86(3): 492-498.[11] Rooks MD, Gould JS, Masear V,et al. Effects of venous hypertension on rabbit free flap survival. Microsurgery. 1991;12(4): 253-261.[12] 易治,翁其彪.高压氧医学教程[M].广州:暨南大学出版社, 2012.[13] Kusumanto Y, Van Weel V,Mulder N,et al.Treatment with intramuscular vascular endothelial growth factor gene compared with placebo for patients with diabetes mellitus and critical limb ischemia: a double-blind randomized trial. Human gene therapy. 2006;17(6): 683-691.[14] 张玉强,李游,曹阳,等.高压氧预处理损伤脊髓 Bcl-2/Bax的表达[J].中国组织工程研究,2013,17(46):8018-8023.[15] 张丽. 高压氧预处理诱导新生大鼠脑缺血耐受的机制研究[J].中华航海医学与高气压医学杂志,2013,20(3):182-185.[16] 王友彬,戚征,高春锦,等.高压氧预处理对皮瓣组织 Cx43和TNF-α表达的影响[J].中华航海医学与高气压医学杂志, 2013,20(1):9-11.[17] Kusumanto Y, Van Weel V,Mulder N,et al.Treatment with intramuscular vascular endothelial growth factor gene compared with placebo for patients with diabetes mellitus and critical limb ischemia: a double-blind randomized trial. Human gene therapy. 2006;17(6):683-691.[18] 周泉. 血管内皮因子的生物学特性及临床研究进展[J].实用心脑肺血管病杂志. 2001;9(1):51-54.[19] McCrary BF. Hyperbaric oxygen (HBO2) treatment for a failing facial flap. Postgrad Med J. 2007;83(975): e1.[20] Ülkür E, Karagoz H, Ergun O, et al. The effect of hyperbaric oxygen therapy on the delay procedure. Plast Reconstr Surg. 2007; 119 (1): 86-94.[21] Friedman HI, Fitzmaurice M, Lefaivre JF, et al. An evidence-based appraisal of the use of hyperbaric oxygen on flaps and grafts. Plast Reconstr Surg. 2006; 117(7S): 175S-190S.[22] Fodor L, Ramon Y, Meilik B, et al. Effect of hyperbaric oxygen on survival of composite grafts in rats. Scand J Plast Reconstr Surg Hand Surg. 2006; 40(5):257-260.[23] Wang XT, Avanessian B, Ma Q, et al. Enhancement of flap survival and changes in angiogenic gene expression after AAV2‐mediated VEGF gene transfer to rat ischemic flaps.Wound Repair and Regeneration. 2011;19(4):498-504.[24] Hunt T. The effect of varying ambient oxygen tensions on wound metabolism and collagen synthesis. Surg Gynecol Obstet. 1972;135:561-567.[25] 刘雪华,高春锦,葛环,等.高压氧对移植皮瓣 VEGF, HIF-1及 CX43 的影响[C].中华医学会第十六次全国高压氧学术会议论,2007.[26] Qi Z, Gao C, Wang Y, et al. Effects of hyperbaric oxygen preconditioning on ischemia-reperfusion inflammation and skin flap survival. Chin Med J (Engl). 2013;126(20):3904-3909.[27] 罗海浪,张永杰,张自强,等.TGFβ1可在体内通过减弱炎症与增强 VEGF分泌抑制脂肪间充质干细胞凋亡[J].医学争鸣,2013,(1):47-47.[28] 马信龙,谢军.VEGF, TGF-β1在骨缺损不愈合中表达的实验研究[J].中华骨科杂志, 2002,22(9):561-566. |